id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0330-0005,FDA,FDA-2008-P-0330,"FDA/CDER Response to Rakoczy Molino Mazzochi Siwik, LLP - Letter",Other,LET-Letter,2009-12-14T05:00:00Z,2009,12,,,2013-08-11T04:36:53Z,,0,0,0900006480a661d0
FDA-2008-P-0330-0004,FDA,FDA-2008-P-0330,"Determination That ABILIFY DISCMELT (Aripiprazole) Orally Disintegrating Tablets, 20 Milligrams and 30 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,N-Notice,2009-12-03T05:00:00Z,2009,12,2009-12-03T05:00:00Z,,2009-12-03T16:28:45Z,E9-28871,0,0,0900006480a6203c
FDA-2008-P-0330-0003,FDA,FDA-2008-P-0330,FDA/CDER Interim Response to Rakoczy Molino Mazzochi Siwik LLP - Letter,Other,LET-Letter,2008-11-24T05:00:00Z,2008,11,2008-11-24T05:00:00Z,,2008-12-20T16:04:33Z,,0,0,09000064807bd8d3
FDA-2008-P-0330-0001,FDA,FDA-2008-P-0330,Rakoczy Molino Mazzochi Siwik LLP - Citizen Petition,Other,CP-Citizen Petition,2008-06-11T04:00:00Z,2008,6,2008-06-11T04:00:00Z,,2008-06-11T23:07:49Z,,0,0,090000648060e36a
FDA-2008-P-0330-0002,FDA,FDA-2008-P-0330,"Acknowledgement Letter to Rakozy Molino Mazzochi Siwik, LLP",Other,ACK-Acknowledgement Letter,2008-06-11T04:00:00Z,2008,6,2008-06-11T04:00:00Z,,2008-11-17T17:59:37Z,,0,0,090000648060e4cc